Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs)

  • Protocol
  • Intervention

Authors


Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To determine the efficacy and safety of methylphenidate for 1) features of ADHD such as hyperactivity, impulsivity, and concentration, and 2) the core features of ASD (social, communication, and behavioural problems) in children aged six to 18 years with ASD.